Multiple Sclerosis Trial, By Invitation NCT03291756 Sponsor: CorEvitas Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, By Invitation

NCT03291756
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Has been diagnosed with multiple sclerosis (MS) at the time of joining the trial.
  • Is 18 years of age or older at the time of joining the trial.
  • Is willing to share personal information as part of the trial.
  • Has been prescribed, or is starting, an approved medication for MS at the time of joining the trial.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are currently taking part in, or planning to take part in, a double-blind randomised trial (a type of study where neither the patient nor the doctor knows which treatment is being given) for an MS drug. Note: taking part in another observational registry or an open-label Phase 3b/4 trial at the same time is permitted.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 24 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
CorEvitas
Registry
ClinicalTrials.gov
Start date
10 August 2017
Est. completion
1 December 2100

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of patients with adverse events (AEs) or serious adverse events (SAEs).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov